Arkolith/Insider Trading/ALKS/Form 4

Hopkinson Craig C.

EVP R&D, Chief Medical OfficerAlkermes plc. (ALKS) · full profile →Form 4 · filed Mar 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$267K
Net Open-Market Flow
-$267K
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Sell(S)9K$29.72$267K89K
Mar 2, 2026Option exercise(M)5K$19.34$97K98K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 2, 2026Option exercise(M)5K—$021K
Mar 2, 2026Grant(A)39K—$039K
Mar 2, 2026Grant(A)83K—$083K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001520262-26-000058) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML